Could a new pill tame cancer Drug's harsh gut side effects?
NCT ID NCT06521762
Summary
This study aimed to see if adding the drug etrasimod to standard steroid treatment could better control severe diarrhea and colon inflammation (colitis) caused by powerful cancer immunotherapies. It planned to enroll adults with advanced cancer who developed this serious side effect. The goal was to reduce the amount and duration of steroids needed, potentially allowing patients to restart their cancer treatment sooner.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IMMUNE CHECKPOINT INHIBITOR-RELATED DIARRHEA AND COLITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Yale Cancer Center
New Haven, Connecticut, 06510, United States
Conditions
Explore the condition pages connected to this study.